Terms: = Ovarian cancer AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha AND Treatment
120 results:
1. cancer-associated fibroblast-secreted FGF7 as an ovarian cancer progression promoter.
Feng S; Ding B; Dai Z; Yin H; Ding Y; Liu S; Zhang K; Lin H; Xiao Z; Shen Y
J Transl Med; 2024 Mar; 22(1):280. PubMed ID: 38491511
[TBL] [Abstract] [Full Text] [Related]
2. Essential role of PLD2 in hypoxia-induced stemness and therapy resistance in ovarian tumors.
Muñoz-Galván S; Verdugo-Sivianes EM; Santos-Pereira JM; Estevez-García P; Carnero A
J Exp Clin Cancer Res; 2024 Feb; 43(1):57. PubMed ID: 38403587
[TBL] [Abstract] [Full Text] [Related]
3. Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors.
Coleman N; Stephen B; Fu S; Karp D; Subbiah V; Ahnert JR; Piha-Paul SA; Wright J; Fessahaye SN; Ouyang F; Yilmaz B; Meric-Bernstam F; Naing A
Cancer Med; 2024 Feb; 13(3):e6877. PubMed ID: 38400671
[TBL] [Abstract] [Full Text] [Related]
4. ALDH1A3 contributes to tumorigenesis in high-grade serous ovarian cancer by epigenetic modification.
Huang J; Tang Y; Li Y; Wei W; Kang F; Tan S; Lin L; Lu X; Wei H; Wang N
Cell Signal; 2024 Apr; 116():111044. PubMed ID: 38211842
[TBL] [Abstract] [Full Text] [Related]
5. Research progress on the mechanism of glycolysis in ovarian cancer.
Li C; Liu FY; Shen Y; Tian Y; Han FJ
Front Immunol; 2023; 14():1284853. PubMed ID: 38090580
[TBL] [Abstract] [Full Text] [Related]
6. Hypoxia promotes the growth and metastasis of ovarian cancer cells by suppressing ferroptosis via upregulating SLC2A12.
Li M; Li L; Cheng X; Li L; Tu K
Exp Cell Res; 2023 Dec; 433(2):113851. PubMed ID: 37940066
[TBL] [Abstract] [Full Text] [Related]
7. Cytotoxic effects of Phenformin on ovarian cancer cells: expression of HIF-1α and PDK1 in the hypoxic microenvironment.
Gunaydin B; Yigitturk G; Elbe H
Rom J Morphol Embryol; 2023; 64(3):355-361. PubMed ID: 37867353
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathological correlations of endometrioid and clear cell carcinomas in the uterus and ovary.
Mori H; Nishida H; Kusaba T; Kawamura K; Oyama Y; Daa T
Medicine (Baltimore); 2023 Sep; 102(37):e35301. PubMed ID: 37713813
[TBL] [Abstract] [Full Text] [Related]
9. Hypoxia-induced PPFIA4 accelerates the progression of ovarian cancer through glucose metabolic reprogramming.
Tan S; Yu H; Xu Y; Zhao Y; Lou G
Med Oncol; 2023 Aug; 40(9):272. PubMed ID: 37596446
[TBL] [Abstract] [Full Text] [Related]
10. Baohuoside I inhibits resistance to cisplatin in ovarian cancer cells by suppressing autophagy via downregulating HIF-1α/ATG5 axis.
Zhou Y; Liu T; Wu Q; Wang H; Sun Y
Mol Carcinog; 2023 Oct; 62(10):1474-1486. PubMed ID: 37283234
[TBL] [Abstract] [Full Text] [Related]
11. In vitro chemo-preventive efficacy of synthetic progestin Norethindrone in human epithelial ovarian cancer.
Sharma A; Sharma I
Med Oncol; 2023 Jun; 40(7):195. PubMed ID: 37270458
[TBL] [Abstract] [Full Text] [Related]
12. BPA exposure enhances the metastatic aggression of ovarian cancer through the ERα/AKT/mTOR/HIF-1α signaling axis.
Xie X; Zhu Y; Cheng H; Li H; Zhang Y; Wang R; Li W; Wu F
Food Chem Toxicol; 2023 Jun; 176():113792. PubMed ID: 37080528
[TBL] [Abstract] [Full Text] [Related]
13. Hypoxia, but Not Normoxia, Reduces Effects of Resveratrol on Cisplatin treatment in A2780 ovarian cancer Cells: A Challenge for Resveratrol Use in Anticancer Adjuvant Cisplatin Therapy.
Synowiec A; Brodaczewska K; Wcisło G; Majewska A; Borkowska A; Filipiak-Duliban A; Gawrylak A; Wilkus K; Piwocka K; Kominek A; Waś H; Lewicki S; Siewiera J; Szczylik C; Szenajch J; Kubiak JZ; Kieda C
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982788
[TBL] [Abstract] [Full Text] [Related]
14. Interleukin-6 and Hypoxia Synergistically Promote EMT-Mediated Invasion in Epithelial ovarian cancer via the IL-6/STAT3/HIF-1
Zhang T; Yang J; Sun Y; Song J; Gao D; Huang S; Pang A; Zhang J; Wang J; Wang Y; Li Y
Anal Cell Pathol (Amst); 2023; 2023():8334881. PubMed ID: 36814597
[TBL] [Abstract] [Full Text] [Related]
15. LncRNA H19 promotes tumor angiogenesis in smokers by targeting anti-angiogenic miRNAs.
Shirvaliloo M
Epigenomics; 2023 Jan; 15(2):61-73. PubMed ID: 36802727
[TBL] [Abstract] [Full Text] [Related]
16. Targeting tumor-stroma communication by blocking endothelin-1 receptors sensitizes high-grade serous ovarian cancer to PARP inhibition.
Tocci P; Roman C; Sestito R; Di Castro V; Sacconi A; Molineris I; Paolini F; Carosi M; Tonon G; Blandino G; Bagnato A
Cell Death Dis; 2023 Jan; 14(1):5. PubMed ID: 36604418
[TBL] [Abstract] [Full Text] [Related]
17. Effects of the exercise-inducible myokine irisin on proliferation and malignant properties of ovarian cancer cells through the HIF-1 α signaling pathway.
Alizadeh Zarei M; Seyed Hosseini E; Haddad Kashani H; Ahmad E; Nikzad H
Sci Rep; 2023 Jan; 13(1):170. PubMed ID: 36599894
[TBL] [Abstract] [Full Text] [Related]
18. Hyperoside protects against cyclophosphamide induced ovarian damage and reduced fertility by suppressing HIF-1α/BNIP3-mediated autophagy.
Zhu F; Gao J; Zeng F; Lai Y; Ruan X; Deng G
Biomed Pharmacother; 2022 Dec; 156():113743. PubMed ID: 36252358
[TBL] [Abstract] [Full Text] [Related]
19. Sevoflurane but not propofol enhances ovarian cancer cell biology through regulating cellular metabolic and signaling mechanisms.
Hu C; Wang B; Liu Z; Chen Q; Ishikawa M; Lin H; Lian Q; Li J; Li JV; Ma D;
Cell Biol Toxicol; 2023 Aug; 39(4):1395-1411. PubMed ID: 36207479
[TBL] [Abstract] [Full Text] [Related]
20. A Multistep Tumor Growth Model of High-Grade Serous ovarian Carcinoma Identifies Hypoxia-Associated Signatures.
More MH; Varankar SS; Naik RR; Dhake RD; Ray P; Bankar RM; Mali AM; Subbalakshmi AR; Chakraborty P; Jolly MK; Bapat SA
Cells Tissues Organs; 2024; 213(2):79-95. PubMed ID: 35970135
[TBL] [Abstract] [Full Text] [Related]
[Next]
